Prevalence of PID by patient characteristics for chlamydia-tested and chlamydia+gonorrhoea-tested women
| Chlamydia-tested (N=15 690) | Chlamydia+gonorrhoea-tested* (N=8839) | |||
|---|---|---|---|---|
| PID/patients | PID/patients | |||
| n/N | Per cent | n/N | Per cent | |
| 436/15 690 | 2.8 | 419/8839 | 4.7 | |
| Age group (years) | ||||
| 16–29 | 359/12 080 | 3.0 | 345/6596 | 5.2 |
| 30–49 | 77/3610 | 2.1 | 74/2243 | 3.3 |
| Country of birth | ||||
| Australia | 188/6529 | 2.9 | 182/3591 | 5.1 |
| Other | 248/9161 | 2.7 | 237/5248 | 4.5 |
| Current contraception | ||||
| Any hormonal | 119/4362 | 2.7 | 114/2185 | 5.2 |
| IUD | 18/263 | 6.8 | 17/157 | 10.8 |
| Other/not reported | 299/11 065 | 2.7 | 288/6497 | 4.4 |
| Symptoms self-reported at triage | ||||
| No | 49/8348 | 0.6 | 46/3005 | 1.5 |
| Yes | 387/7342 | 5.3 | 373/5834 | 6.4 |
| STI contact | ||||
| No | 397/14 652 | 2.7 | 383/8322 | 4.6 |
| Yes | 39/1038 | 3.8 | 36/517 | 7.0 |
| Chlamydia test results | ||||
| Negative | 342/14 411 | 2.4 | NA | |
| Positive | 94/1279 | 7.4 | NA | |
| Chlamydia and gonorrhoea test results | ||||
| Negative | NA | 327/8106 | 4.0 | |
| Chlamydia positive only | NA | 82/681 | 12.0 | |
| Gonorrhoea positive only | NA | 5/30 | 16.7 | |
| Chlamydia and gonorrhoea positive | NA | 5/22 | 22.7 | |
| Male sexual partners, last 3 months | ||||
| None | 10/1239 | 0.8 | 10/660 | 1.5 |
| 1 | 231/8059 | 2.9 | 225/4628 | 4.8 |
| ≥2 | 195/6392 | 3.1 | 187/3551 | 5.3 |
| Condom use with male partners, last 3 months | ||||
| No male partners/vaginal sex | 11/1351 | 0.8 | 11/715 | 1.5 |
| Always | 44/2572 | 1.7 | 44/1267 | 3.5 |
| Not always | 381/11 767 | 3.2 | 364/6857 | 5.3 |
| Male sexual partners, last 12 months | ||||
| None | 3/514 | 0.6 | 3/273 | 1.1 |
| 1 | 117/4059 | 2.9 | 113/2457 | 4.6 |
| 2 | 90/3418 | 2.6 | 86/1873 | 4.6 |
| ≥3 | 226/7699 | 2.9 | 217/4236 | 5.1 |
| Condom use with male partners, last 12 months | ||||
| No male partners/vaginal sex | 5/612 | 0.8 | 5/323 | 1.6 |
| Always | 38/2299 | 1.7 | 38/1149 | 3.3 |
| Not always | 393/12 779 | 3.1 | 376/7367 | 5.1 |
*Chlamydia+gonorrhoea tested group is a subset of the chlamydia-tested group.
IUD, intrauterine device; NA, not applicable; PID, pelvic inflammatory disease; STI, sexually transmitted infection.